Global companion diagnostic market is expected to reach USD38.79 billion by 2026, growing at double-digit CAGR of 11.13% over the forecast period. The key factor responsible for the growth of companion diagnostic market is the growing cases of cancer across the globe. Additionally, increase in requirement for targeted therapy is another major factor which is anticipated to bode well for the growth of companion diagnostic market in the coming years. Moreover, rising number of clinical trials is further anticipated to bolster the market growth until 2026.

Global companion diagnostic market is segmented based on products and services, technology, disease indication, end-user, application, company, and region. The market can be segmented into pharmaceutical & biotechnology companies, research laboratories, contract research organization, and others based on end-user. Out of these, the pharmaceutical & biotechnology companies dominated the market in terms of largest market share until 2020 and is further anticipated to be the fastest-growing application segment in the companion diagnostic market during the next five years as well. This growth can be accredited to the widespread use of companion diagnostics in such industries because of their increasing stronghold in the drug development sector as well as the growing importance of companion diagnostic biomarkers. Additionally, surge in requirement for personalized medicines coupled with high demand for targeted therapies for the treatment of multiple diseases and disorders is further boosting the growth of the segment across the globe.

Major players operating in the global companion diagnostic market include Thermo Fisher Scientific Inc., Illumina Inc., Bayer AG, Quest Diagnostics Inc., Danaher Corporation, Qiagen NV, Seimens Healthineers AG, F. Hoffmann-La Roche AG, Agilent Technologies Inc., Abbott Laboratories Inc., DiaSorin SpA (Luminex Corporation), Icon Plc (MolecularMD Corporation), Myriad Genetics Inc., Biogenex Laboratories Inc., bioMérieux SA and others. The companies operating in the global companion diagnostic market are focusing on expanding their share in the market. For instance, these key players are making organic strategies such as new product launches & approvals, among others in order to enrich their consumer base. 

Years considered for this report:

Historical Years: 2016-2019                                                                         

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022-2026

Objective of the Study:

  • To analyze the historical growth in the market size of global companion diagnostic market from 2016 to 2020.
  • To estimate and forecast the market size of global companion diagnostic market from 2021 to 2026 and growth rate until 2026.
  • To classify and forecast global companion diagnostic market based on products and services, technology, disease indication, end-user, application, company and region.
  • To identify drivers and challenges for global companion diagnostic market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global companion diagnostic market.
  • To conduct pricing analysis for global companion diagnostic market.
  • To identify and analyse the profile of leading players operating in global companion diagnostic market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of hospitals/clinics across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals/clinics which could not be identified due to the limitations of secondary research. TechSci Research analyzed the new products, technologies and presence of all major players across the globe.

TechSci Research calculated the market size of global companion diagnostic market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Companion diagnostic hospitals/clinics, research institutes and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to companion diagnostic  
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals/clinics and partners, end-users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global companion diagnostic market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Companion Diagnostic Market, By Products and Services:
    • Kits and Reagents
    • Assays
    • Software and Services
  • Global Companion Diagnostic Market, By Technology:
    • Polymerase Chain Reaction (PCR)
    • Next Generation Sequencing (NGS)
    • In-situ Hybridization
    • Immunohistochemistry
    • Others
  • Global Companion Diagnostic Market, By Disease Indication:
    • Oncology
    • Neurology
    • Cardiology
    • Infectious Diseases
    • Others
  • Global Companion Diagnostic Market, By End-User:
    • Pharmaceutical & Biotechnology Companies
    • Research Laboratories
    • Contract research organization
    • Others
  • Global Companion Diagnostic Market, By Application:
    • In-Vitro diagnostics
    • Drug Discovery
    • Others
  • Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Singapore
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East and Africa
      • South Africa
      • Saudi Arabia
      • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global companion diagnostic market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Global Companion Diagnostic Market

4.    Executive Summary

5.    Voice of Customer

5.1.  Factors Driving the Companion Diagnostic Market

5.2.  Brand Awareness

5.3.  Customer Satisfaction Analysis

6.    Global Companion Diagnostic Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Products and Services (Kits and Reagents, Assays, Software and Services)

6.2.2.     By Technology (Polymerase Chain Reaction (PCR), Next-Generation sequencing (NGS), In-Situ Hybridization, Immunohistochemistry and Others)

6.2.3.     By Disease Indication (Oncology, Neurology, Cardiology, Infectious Diseases and Others)

6.2.4.     By End-User (Pharmaceutical & Biotechnology Companies, Research Laboratories, Contract Research Organization and Others)

6.2.5.     By Application (In-Vitro Diagnostics, Drug Discovery and Others)

6.2.6.     By Company (2020)

6.2.7.     By Region

6.3.  Product Market Map

7.    North America Companion Diagnostic Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Products and Services

7.2.2.     By Technology

7.2.3.     By Disease Indication

7.2.4.     By End User

7.2.5.     By Application

7.2.6.     By Country

7.3.  North America: Country Analysis

7.3.1.     United States Companion Diagnostic Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Products and Services

7.3.1.2.2.             By Technology

7.3.1.2.3.             By Disease Indication

7.3.1.2.4.             By End User

7.3.1.2.5.             By Application

7.3.2.     Canada Companion Diagnostic Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Products and Services

7.3.2.2.2.             By Technology

7.3.2.2.3.             By Disease Indication

7.3.2.2.4.             By End User

7.3.2.2.5.             By Application

7.3.3.     Mexico Companion Diagnostic Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Products and Services

7.3.3.2.2.             By Technology

7.3.3.2.3.             By Disease Indication

7.3.3.2.4.             By End User

7.3.3.2.5.             By Application

8.    Europe Companion Diagnostic Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Products and Services

8.2.2.     By Technology

8.2.3.     By Disease Indication

8.2.4.     By End User

8.2.5.     By Application

8.2.6.     By Country

8.3.  Europe: Country Analysis

8.3.1.     Germany Companion Diagnostic Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Products and Services

8.3.1.2.2.             By Technology

8.3.1.2.3.             By Disease Indication

8.3.1.2.4.             By End User

8.3.1.2.5.             By Application

8.3.2.     United Kingdom Companion Diagnostic Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Products and Services

8.3.2.2.2.             By Technology

8.3.2.2.3.             By Disease Indication

8.3.2.2.4.             By End User

8.3.2.2.5.             By Application

8.3.3.     France Companion Diagnostic Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Products and Services

8.3.3.2.2.             By Technology

8.3.3.2.3.             By Disease Indication

8.3.3.2.4.             By End User

8.3.3.2.5.             By Application

8.3.4.     Italy Companion Diagnostic Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Products and Services

8.3.4.2.2.             By Technology

8.3.4.2.3.             By Disease Indication

8.3.4.2.4.             By End User

8.3.4.2.5.             By Application

8.3.5.     Spain Companion Diagnostic Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Products and Services

8.3.5.2.2.             By Technology

8.3.5.2.3.             By Disease Indication

8.3.5.2.4.             By End User

8.3.5.2.5.             By Application

9.    Asia-Pacific Companion Diagnostic Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Products and Services

9.2.2.     By Technology

9.2.3.     By Disease Indication

9.2.4.     By End User

9.2.5.     By Application

9.2.6.     By Country

9.3.  Asia-Pacific: Country Analysis

9.3.1.     China Companion Diagnostic Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Products and Services

9.3.1.2.2.             By Technology

9.3.1.2.3.             By Disease Indication

9.3.1.2.4.             By End User

9.3.1.2.5.             By Application

9.3.2.     Japan Companion Diagnostic Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Products and Services

9.3.2.2.2.             By Technology

9.3.2.2.3.             By Disease Indication

9.3.2.2.4.             By End User

9.3.2.2.5.             By Application

9.3.3.     India Companion Diagnostic Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Products and Services

9.3.3.2.2.             By Technology

9.3.3.2.3.             By Disease Indication

9.3.3.2.4.             By End User

9.3.3.2.5.             By Application

9.3.4.     South Korea Companion Diagnostic Market Outlook

9.3.4.1.         Market Size & Forecast

9.3.4.1.1.             By Value

9.3.4.2.         Market Share & Forecast

9.3.4.2.1.             By Products and Services

9.3.4.2.2.             By Technology

9.3.4.2.3.             By Disease Indication

9.3.4.2.4.             By End User

9.3.4.2.5.             By Application

9.3.5.     Australia Companion Diagnostic Market Outlook

9.3.5.1.         Market Size & Forecast

9.3.5.1.1.             By Value

9.3.5.2.         Market Share & Forecast

9.3.5.2.1.             By Products and Services

9.3.5.2.2.             By Technology

9.3.5.2.3.             By Disease Indication

9.3.5.2.4.             By End User

9.3.5.2.5.             By Application

9.3.6.     Singapore Companion Diagnostic Market Outlook

9.3.6.1.         Market Size & Forecast

9.3.6.1.1.             By Value

9.3.6.2.         Market Share & Forecast

9.3.6.2.1.             By Products and Services

9.3.6.2.2.             By Technology

9.3.6.2.3.             By Disease Indication

9.3.6.2.4.             By End User

9.3.6.2.5.             By Application

10.  South America Companion Diagnostic Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Products and Services

10.2.2.  By Technology

10.2.3.  By Disease Indication

10.2.4.  By End User

10.2.5.  By Application

10.2.6.  By Country

10.3.              South America: Country Analysis

10.3.1.  Brazil Companion Diagnostic Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Products and Services

10.3.1.2.2.           By Technology

10.3.1.2.3.           By Disease Indication

10.3.1.2.4.           By End User

10.3.1.2.5.           By Application

10.3.2.  Argentina Companion Diagnostic Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Products and Services

10.3.2.2.2.           By Technology

10.3.2.2.3.           By Disease Indication

10.3.2.2.4.           By End User

10.3.2.2.5.           By Application

10.3.3.  Colombia Companion Diagnostic Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Products and Services

10.3.3.2.2.           By Technology

10.3.3.2.3.           By Disease Indication

10.3.3.2.4.           By End User

10.3.3.2.5.           By Application

11.  Middle East and Africa Companion Diagnostic Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Products and Services

11.2.2.  By Technology

11.2.3.  By Disease Indication

11.2.4.  By End User

11.2.5.  By Application

11.2.6.  By Country

11.3.              MEA: Country Analysis

11.3.1.  South Africa Companion Diagnostic Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Products and Services

11.3.1.2.2.           By Technology

11.3.1.2.3.           By Disease Indication

11.3.1.2.4.           By End User

11.3.1.2.5.           By Application

11.3.2.  Saudi Arabia Companion Diagnostic Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Products and Services

11.3.2.2.2.           By Technology

11.3.2.2.3.           By Disease Indication

11.3.2.2.4.           By End User

11.3.2.2.5.           By Application

11.3.3.  UAE Companion Diagnostic Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Products and Services

11.3.3.2.2.           By Technology

11.3.3.2.3.           By Disease Indication

11.3.3.2.4.           By End User

11.3.3.2.5.           By Application

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends & Developments

14.  Competitive Landscape

14.1.              Competition Outlook

14.2.              Players Profiled (Leading Companies)

14.2.1.  Thermo Fisher Scientific Inc.

14.2.2.  Illumina Inc.

14.2.3.  Bayer AG

14.2.4.  Quest Diagnostics Inc.

14.2.5.  Danaher Corporation

14.2.6.  Qiagen NV

14.2.7.  Seimens Healthineers AG

14.2.8.  F. Hoffmann-La Roche AG

14.2.9.  Agilent Technologies Inc.

14.2.10. Abbott Laboratories Inc.

14.2.11. DiaSorin SpA (Luminex Corporation)

14.2.12. Icon Plc (MolecularMD Corporation)

14.2.13. Myriad Genetics Inc.

14.2.14. Biogenex Laboratories Inc.

14.2.15. bioMérieux SA

15.  Strategic Recommendations

16.  About Us & Disclaimer

  • List of Figures

    Figure 1: Global Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F                

    Figure 2: Global Companion Diagnostic Market Share, By Products and Services, By Value, By Value, 2016-2026F 

    Figure 3: Global Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F

    Figure 4: Global Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F

    Figure 5: Global Companion Diagnostic Market Share, By End User, By Value, 2016-2026F

    Figure 6: Global Companion Diagnostic Market Share, By Application, By Value, 2016-2026F

    Figure 7: Global Companion Diagnostic Market Share, By Company, By Value, 2020                           

    Figure 8: Global Companion Diagnostic Market Share, By Region, By Value, 2016-2026F                  

    Figure 9: Global Companion Diagnostic Product Market Map, By Value, 2016-2026F                           

    Figure 10: North America Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F

    Figure 11: North America Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F  

    Figure 12: North America Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F  

    Figure 13: North America Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F                              

    Figure 14: North America Companion Diagnostic Market Share, By End User, By Value, 2016-2026F

    Figure 15: North America Companion Diagnostic Market Share, By Application, By Value, 2016-2026F 

    Figure 16: North America Companion Diagnostic Market Share, By Country, By Value, 2016-2026F

    Figure 17: United States Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F

    Figure 18: United States Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F                                   

    Figure 19: United States Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F 

    Figure 20: United States Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F                                    

    Figure 21: United States Companion Diagnostic Market Share, By End User, By Value, 2016-2026F

    Figure 22: United States Companion Diagnostic Market Share, By Application, By Value, 2016-2026F    

    Figure 23: Canada Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F             

    Figure 24: Canada Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F  

    Figure 25: Canada Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F     

    Figure 26: Canada Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F      

    Figure 27: Canada Companion Diagnostic Market Share, By End User, By Value, 2016-2026F          

    Figure 28: Canada Companion Diagnostic Market Share, By Application, By Value, 2016-2026F     

    Figure 29: Mexico Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F              

    Figure 30: Mexico Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F 

    Figure 31: Mexico Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F     

    Figure 32: Mexico Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F 

    Figure 33: Mexico Companion Diagnostic Market Share, By End User, By Value, 2016-2026F

    Figure 34: Mexico Companion Diagnostic Market Share, By Application, By Value, 2016-2026F

    Figure 35: Europe Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F              

    Figure 36: Europe Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F                                      

    Figure 37: Europe Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F     

    Figure 38: Europe Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F                                          

    Figure 39: Europe Companion Diagnostic Market Share, By End User, By Value, 2016-2026F          

    Figure 40: Europe Companion Diagnostic Market Share, By Application, By Value, 2016-2026F     

    Figure 41: Europe Companion Diagnostic Market Share, By Country, By Value, 2016-2026F             

    Figure 42: Germany Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F          

    Figure 43: Germany Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F 

    Figure 44: Germany Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F

    Figure 45: Germany Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F 

    Figure 46: Germany Companion Diagnostic Market Share, By End User, By Value, 2016-2026F      

    Figure 47: Germany Companion Diagnostic Market Share, By Application, By Value, 2016-2026F

    Figure 48: United Kingdom Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F

    Figure 49: United Kingdom Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F   

    Figure 50: United Kingdom Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F                                         

    Figure 51: United Kingdom Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F

    Figure 52: United Kingdom Companion Diagnostic Market Share, By End User, By Value, 2016-2026F 

    Figure 53: United Kingdom Companion Diagnostic Market Share, By Application, By Value, 2016-2026F                                           

    Figure 54: France Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F            &n